Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2020-08-07 19:51:29
Reporting Period:
Accepted Time:
2020-08-07 19:51:29
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
914475 Neurocrine Biosciences Inc NBIX Biological Products, (No Disgnostic Substances) (2836) 330525145
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1727606 Eiry Roberts 12780 El Camino Real
San Diego CA 92130
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2020-08-05 2,257 $118.84 11,446 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
  1. Sale of 2,257 shares of common stock issued upon vesting of 4,287 performance restricted stock units to cover withholdingtaxes, with the balance of the shares (2,030) maintained by the Reporting Person. The disposition reported in this Form 4 was effected by abroker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the Reporting Person at least 60 days prior to the transactiondate in Box 3 above. Additionally, Issuer policy restricts the Reporting Person from amending or otherwise modifying any 10b5-1 trading plansubsequent to adoption of the plan.
  2. Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $118.21 to $120.56. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.